Dose Reduction of Biologics Effective, Safe for Psoriasis

FRIDAY, June 5, 2026-- For patients with psoriasis with stable low disease activity, dose reduction (DR) through stepwise interval prolongation of interleukin (IL)-17 and 23 inhibitors (i) is effective and safe, according to a study published...